Showing results (211-220 of 250) with videos related to

Sort By:
Pageof 25
Archives of Medical Science : AMS|September 1, 2015
Sulfonylureas and their use in clinical practiceDaniele Sola, Luca Rossi, Gian Piero Carnevale Schianca, et al.
Metabolism: Clinical and Experimental|April 29, 2010
Effects of combination of sibutramine and L-carnitine compared with sibutramine monotherapy on inflammatory parameters in diabetic patientsGiuseppe Derosa, Pamela Maffioli, Sibilla A T Salvadeo, et al.
Drug Design, Development and Therapy|August 24, 2017
Ambulatory blood pressure parameters after canrenone addition to existing treatment regimens with maximum tolerated dose of angiotensin-converting enzyme inhibitors/angiotensin II type 1 receptor blockers plus hydrochlorothiazide in uncontrolled hypertensive patientsLuigina Guasti, Giovanni Gaudio, Alessandro Lupi, et al.
Endothelium : Journal of Endothelial Cell Research|March 17, 2007
Metalloproteinase-2 and -9 in diabetic and nondiabetic subjects during acute coronary syndromesGiuseppe Derosa, Arrigo F G Cicero, Filippo Scalise, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|May 28, 2010
Differential effects of candesartan and olmesartan on adipose tissue activity biomarkers in type II diabetic hypertensive patientsGiuseppe Derosa, Pamela Maffioli, Sibilla A T Salvadeo, et al.
Internal Medicine (Tokyo, Japan)|August 20, 2010
Sibutramine and L-carnitine compared to sibutramine alone on insulin resistance in diabetic patientsGiuseppe Derosa, Pamela Maffioli, Sibilla A T Salvadeo, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 9, 2020
Lipid-lowering nutraceuticals update on scientific evidenceGiuseppe Derosa, Alessandro Colletti, Pamela Maffioli, et al.
American Journal of Hypertension|December 4, 2002
Effects of amlodipine fosinopril combination on microalbuminuria in hypertensive type 2 diabetic patientsRoberto Fogari, Paola Preti, Annalisa Zoppi, et al.
Diabetes, Obesity & Metabolism|January 25, 2017
Phase III, efficacy and safety study of ertugliflozin monotherapy in people with type 2 diabetes mellitus inadequately controlled with diet and exercise aloneSteven G Terra, Kristen Focht, Melanie Davies, et al.
Cardiovascular Therapeutics|November 19, 2016
Efficacy and safety of two dosages of canrenone as add-on therapy in hypertensive patients taking ace-inhibitors or angiotensin II receptor blockers and hydrochlorothiazide at maximum dosage in a randomized clinical trial: The ESCAPE-IT trialGiuseppe Derosa, Pamela Maffioli, Maria D'Avino, et al.
Pageof 25